Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Bio-Vascular, Inc. (NasdaqNM:BVAS)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Recent Events
Aug 22Conference call: Bio-Vascular Earnings (Q3 2001)
Aug 22Earnings Announcement
Aug  2Price hit new 52-week high ($9.89)
Location
2575 University Avenue
St. Paul, MN 55114
Phone: (651) 603-3700
Fax: (651) 371-0707
Email: info@biovascular.com
Employees (last reported count): 230
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 20%
·Over the last 6 months:
 · one insider sell; 2,000  shares
  (0.1% of insider shares)
·Institutional: 16% (20% of float)
(23 institutions)
·Net Inst. Buying: 377.0K shares (+20.52%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Bio-Vascular, Inc. is a diversified medical device company, engaged in developing, manufacturing and marketing products to improve the quality of human life. The Company operates through two business units. The Branded Medical Device business includes branded implantable biomaterials, surgical productivity tools and licensed and distributed products for use in critical surgeries, including bariatric (stomach and intestines), thoracic (chest and lungs), cardiac (heart), neurosurgical (brain and spine), and vascular (arteries and veins) surgeries. Branded Medical Devices are manufactured using the Company's patented and proprietary technologies. Jerneen Micro Medical Technologies, a wholly onwed subsidiary, custom designs, engineers and manufactures precision micro wire components that are used primarily in implantable interventional cardiovascular and neurological devices, such as pacemakers, defibrillators and neuro and spinal electro-stimulation devices.
More from Market Guide: Expanded Business Description

Financial Summary
Bio-Vascular, Inc. develops, manufactures and markets branded proprietary and patented specialty medical products for use in thoracic, cardiac, neuro, vascular and ophthalmic surgery. For the six months ended 4/30/01, revenues rose 37% to $13.4 million. Net income totaled $780 thousand vs. a loss of $167 thousand. Revenues reflect an increase in domestic Peri-Strips sales and Micro Medical Technologies segment sales. Earnings also reflects lower personnel expenses.

Recent Earnings Announcement
For the 3 months ended 07/31/2001, revenues were 7,087; after tax earnings were 503. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Timothy Scanlan, 54
Chairman
--  --  
M. Karen Gilles, 58
Pres, CEO
$256K$11K
Connie Magnuson, 39
VP of Fin., CFO and Corp. Sec.
152K--  
Evan Johnston, 40
VP-Operations
--  --  
David Buche, 39
VP of Marketing and Sales
162K--  
Dollar amounts are as of 31-Oct-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:BVASAs of 31-Aug-2001
Price and Volume
52-Week Low
on 30-Nov-2000
$3.625
Recent Price$6.60 
52-Week High
on 2-Aug-2001
$9.89 
Beta0.44 
Daily Volume (3-month avg)80.3K
Daily Volume (10-day avg)110.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+53.0%
52-Week Change
relative to S&P500
+105.3%
Share-Related Items
Market Capitalization$59.6M
Shares Outstanding9.03M
Float7.20M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)$2.51 
Earnings (ttm)$0.17 
Earnings (mrq)$0.05 
Sales (ttm)$2.78 
Cash (mrq*)$0.67 
Valuation Ratios
Price/Book (mrq*)2.63 
Price/Earnings (ttm)38.15 
Price/Sales (ttm)2.38 
Income Statements
Sales (ttm)$26.3M
EBITDA (ttm*)$2.46M
Income available to common (ttm)$1.64M
Profitability
Profit Margin (ttm)6.2%
Operating Margin (ttm)9.6%
Fiscal Year
Fiscal Year EndsOct 31
Most recent quarter
(fully updated)
30-Apr-2001
Most recent quarter
(flash earnings)
31-July-2001
Management Effectiveness
Return on Assets (ttm)6.53%
Return on Equity (ttm)7.48%
Financial Strength
Current Ratio (mrq*)4.67 
Debt/Equity (mrq*)0.02 
Total Cash (mrq)$5.29M
Short Interest
As of 8-Aug-2001
Shares Short29.0K
Percent of Float0.4%
Shares Short
(Prior Month)
31.0K
Short Ratio0.27 
Daily Volume109.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 31-July-2001, except mrq*/ttm* items as of 30-Apr-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Some event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.